Pfizer ends agreement to develop Remoxy
October 27, 2014 at 08:05 AM EDT
Pfizer ended its agreement with Pain Therapeutics to develop and commercialize Remoxy, an extended-release version of oxycodone. Pain Therapeutics had licensed Remoxy from Durect Corp.
